Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy

Clinical trial NCT01316458 · COMPLETED

Trial details

NCT number: NCT01316458
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasm Genital Neoplasms, Male Neoplasms, Abdominal Urogenital Neoplasms Genital Diseases, Male Prostatic Diseases Antineoplastic Agents Imatinib

Start date: 2003-06-01
Primary completion: 2010-07-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.